⚠ Critical Care

Advanced Cardiac Life Support (ACLS/ALS)
Nursing Guide

Comprehensive evidence-based ACLS/ALS reference for GCC nurses covering algorithms, airway management, arrhythmias, post-resuscitation care, team dynamics, and exam preparation aligned with ERC/SHA guidelines.

📅 Updated April 2026 🏴 ERC 2021 / SHA / Emirates Cardiac Society 🆂 GCC Clinical Practice 📋 DHA / DOH / SCFHS Aligned
Recognition of Cardiac Arrest
  • Unresponsive: no response to voice or pain stimulus
  • Not breathing normally: absent or agonal (gasping) breathing — agonal breathing is NOT normal and is a sign of cardiac arrest
  • Pulse check: 10 seconds maximum — if in doubt, start CPR
Key Point Agonal breathing (irregular, infrequent gasping) is frequently mistaken for normal breathing. It signals cardiac arrest — begin CPR immediately.
Immediate Actions
  • Call the resuscitation team / activate emergency response
  • Get the AED/defibrillator — bring to bedside
  • Start CPR without delay
  • Assign roles clearly as team arrives
High-Quality CPR Metrics
ParameterTarget
Rate100–120 compressions/min
Depth5–6 cm (sternum to spine)
Full RecoilAllow complete chest recoil after each compression — do not lean
Interruptions<5 seconds for any pause; aim >80% CCF
Ventilation ratio30:2 until advanced airway secured; then continuous compressions + 10 breaths/min
Compressor rotationEvery 2 minutes — fatigue degrades quality
ALS Algorithm Flow
Start
Unresponsive + Not breathing normally → Call team + Get defibrillator → Start CPR 30:2
Rhythm Check (every 2 min)
Attach defibrillator pads → Pause CPR <5 sec → Assess rhythm
⚡ Shockable: VF / pVT
Shock 200J biphasic (or per device)
Resume CPR immediately for 2 min
Reassess rhythm
3rd shock → Adrenaline 1mg IV + Amiodarone 300mg IV
Adrenaline 1mg every 3–5 min thereafter
5th shock → Amiodarone 150mg IV
▷ Non-Shockable: PEA / Asystole
Resume CPR immediately for 2 min
Adrenaline 1mg IV as soon as IV access
Repeat adrenaline every 3–5 min
Treat reversible causes (4Hs & 4Ts)
Reversible Causes — 4Hs & 4Ts
4Hs
  • Hypoxia — ensure effective ventilation, high-flow O₂
  • Hypovolaemia — IV fluid bolus, find haemorrhage source
  • Hypo/Hyperkalaemia & metabolic — check electrolytes, ECG, calcium chloride for hyperkalaemia
  • Hypothermia — warm IV fluids, active external rewarming, consider ECMO
4Ts
  • Tension pneumothorax — needle decompression (2nd ICS MCL or 4th ICS anterior axillary)
  • Tamponade (cardiac) — pericardiocentesis or surgical drainage
  • Toxins — specific antidotes (naloxone/intralipid etc.)
  • Thrombosis — pulmonary embolism (thrombolysis) or coronary (cath lab)
ROSC — Signs of Return of Spontaneous Circulation
💓
Organised cardiac rhythm Identifiable rhythm on monitor (not VF/pVT/asystole) with palpable pulse
🔴
SpO₂ improving Rising oxygen saturation on pulse oximetry — may take 1–2 minutes to register
📈
ETCO₂ rise (most reliable during CPR) Sudden rise in end-tidal CO₂ >10 mmHg strongly suggests ROSC — the gold standard indicator during ongoing CPR
🌞
Clinical signs Patient moves, coughs, eye opening, BP recordable
ETCO₂ During CPR Low ETCO₂ (<10 mmHg) despite CPR = poor cardiac output. A sudden sustained rise (>10–40 mmHg) = ROSC. ETCO₂ also confirms ET tube placement.
Airway Adjuncts
OPA — Oropharyngeal Airway (Guedel) Sizing: corner of mouth to earlobe (or centre of mouth to angle of jaw). Use in unconscious patients with no gag reflex. Insert rotated 180°, then rotate back. Sizes: 2 (small adult), 3 (medium adult), 4 (large adult).
NPA — Nasopharyngeal Airway Size: diameter of patient's little finger (typically 6–7mm). Tolerated in semi-conscious patients. CONTRAINDICATED in suspected base of skull fracture (signs: Battle's sign, raccoon eyes, blood/CSF from nose/ears, haemotympanum).
BVM Ventilation
  • C-E grip: C = thumb + index fingers form seal, E = remaining 3 fingers lift jaw
  • Tidal volume: 500–600 mL (visible chest rise only)
  • Rate: 10 breaths/min once advanced airway secured; 30:2 before
  • Two-person technique preferred for better seal and reduced fatigue
  • Avoid hyperventilation — increases intrathoracic pressure, reduces coronary perfusion
Suction Devices
  • Yankauer (rigid): oral cavity, pharynx — large bore, effective for secretions/vomit
  • Flexible catheter: nasotracheal/through ET tube — size = (ET tube size - 2) × 2
  • Suction pressure: 80–120 mmHg (adult) — apply only on withdrawal
  • Duration: <10 seconds per pass — re-oxygenate before/after
Surgical Airway
  • Needle cricothyroidotomy: 14G cannula through cricothyroid membrane, attach jet oxygenation (15L/min) — temporary (<30–45 min), buys time
  • Surgical cricothyrotomy: definitive emergency airway — horizontal stab incision through cricothyroid membrane, dilate, insert 6.0 cuffed ET or tracheostomy tube
  • Cricothyroid membrane: below thyroid cartilage, above cricoid cartilage — palpable midline landmark
Supraglottic Airways (SGAs)
DeviceKey FeatureAdult Size
Classic LMACuffed, reusable, first SGA3 = small adult F, 4 = adult F/M, 5 = large M
i-gelNo inflatable cuff — soft gel seal, easier insertion, gastric drain channel3, 4, 5 by weight
LMA ProSealHigher seal pressure, gastric drain port3, 4, 5
LMA SupremeDisposable, intubating channel, curved3, 4, 5
SGA Advantage in Arrest Faster insertion than ETI; allows continuous compressions without pausing for laryngoscopy. Preferred first-line advanced airway in many ALS protocols unless experienced intubator available.
Endotracheal Intubation — RSI Sequence
Step 1 — Preoxygenation
100% O₂ via BVM or NRB mask for 3–5 min; aim SpO₂ >94%
Step 2 — Cricoid Pressure (Sellick's)
10N awake, 30N on induction — controversial but still used; reduces gastric regurgitation risk
Step 3 — Sedation + Paralysis
e.g. Ketamine 1–2 mg/kg IV + Suxamethonium 1–1.5 mg/kg IV (or rocuronium 1.2 mg/kg if sux contraindicated)
Step 4 — Laryngoscopy + Intubation
Direct or video laryngoscopy; tube size adult ♀ 7.0–7.5, ♂ 8.0–9.0; cuff inflation to 20–30 cmH₂O
Step 5 — Confirm Position
5-point auscultation + ETCO₂ waveform + CXR
ET Tube Confirmation
Oesophageal Intubation Warning Epigastric gurgling on auscultation = tube in oesophagus. REMOVE IMMEDIATELY. This is a life-threatening error.
  • 5-point auscultation: epigastrium FIRST (gurgling = wrong), then left base, right base, left apex, right apex (bilateral equal breath sounds = correct)
  • ETCO₂ waveform: gold standard for confirming tracheal placement AND adequate perfusion; persistent waveform over 6 breaths = tracheal
  • CXR: confirm tip 3–5 cm above carina (at level of clavicular heads)
  • Tube depth: typically 21 cm at lips for females, 23 cm for males
Difficult Airway Manoeuvres BURP (Backward-Upward-Rightward Pressure on thyroid cartilage) improves laryngeal view. Bougie (gum elastic bougie) guides tube when cords not fully visible. Videolaryngoscopy (McGrath/GlideScope) for predicted difficult airway.
Adverse Features — Act Immediately
4 Adverse Features (Any = Unstable) 1. Shock (systolic BP <90 mmHg, pale/sweaty, altered consciousness)   2. Syncope (presyncope/collapse)   3. Myocardial ischaemia (chest pain, ST changes)   4. Heart failure (acute pulmonary oedema, severe dyspnoea, raised JVP)
Unstable Tachycardia — Any Cause IMMEDIATE synchronised DC cardioversion. Start at 120–150J biphasic, escalate (150J → 200J → 360J equivalent). Sedate with midazolam/ketamine/propofol if conscious. Synchronise to avoid R-on-T phenomenon.
Stable Broad Complex Tachycardia (BCT)
  • Regular BCT = treat as VT until proven otherwise
  • IV Amiodarone 300mg over 20–60 min (loading dose), then 900mg over 24h
  • If confirmed SVT with aberrant conduction — adenosine may be used
  • Avoid verapamil in BCT — may precipitate haemodynamic collapse
Stable Narrow Complex Tachycardia (SVT)
Step 1 — Vagal Manoeuvres
Modified Valsalva (most effective): 40 mmHg blowing into syringe for 15 sec, then immediately supine + legs raised 45° for 15 sec → converts ~43% SVT (REVERT trial). Carotid sinus massage (contraindicated if carotid bruit).
↓ if fails
Step 2 — Adenosine
6mg rapid IV bolus via large antecubital vein, immediately flush with 20mL saline. Warn patient: brief feeling of cardiac arrest/chest tightness (seconds). Record 12-lead ECG throughout. Repeat 12mg if no response, then 12mg again (max 3 doses).
↓ if fails or recurs
Step 3 — Consider rate control
Verapamil 5–10mg IV (if no pre-excitation) or beta-blocker IV. Seek senior/cardiology review.
AF Management
  • Rate control: beta-blockers (metoprolol) or rate-limiting CCBs (diltiazem/verapamil) or digoxin
  • Cardioversion: only if onset <48h OR anticoagulated for ≥3 weeks
  • Anticoagulation: heparin immediately if cardioversion planned; DOAC/warfarin long-term based on CHA₂DS₂-VASc score
  • If >48h onset and NOT anticoagulated — rate control only; DO NOT cardiovert (thromboembolic risk)
WPW + AF (Pre-excited AF) — CRITICAL WARNING DO NOT give AV nodal blockers: adenosine, verapamil, diltiazem, digoxin, amiodarone. These block the AV node and force conduction down the accessory pathway → rapid ventricular rate → VF. Treatment: DC cardioversion (preferred) or flecainide IV.
Symptomatic Bradycardia
InterventionDetails
Atropine500 mcg IV bolus; repeat every 3–5 min; max 3 mg total. First-line for all symptomatic bradycardias.
Transcutaneous pacing (TCP)If atropine ineffective or Mobitz II/3° block. Apply pads (anterior-posterior preferred). Set rate 70–80/min; increase mA until capture (electrical + mechanical). Sedate for comfort.
Adrenaline infusion2–10 mcg/min IV as bridge to TCP/transvenous pacing. Mix: 1mg adrenaline in 100mL 0.9% NaCl = 10 mcg/mL.
Transvenous pacingDefinitive for persistent high-degree block. Internal jugular or subclavian access; right ventricular pacing.
Pacemaker Failure During Arrest Do NOT defibrillate directly over pacemaker/ICD generator. Place pads at least 8 cm away. A pacing spike on ECG with no subsequent QRS complex = capture failure — treat as arrest and continue CPR.
Torsades de Pointes (TdP)
  • Polymorphic VT on long QT background — twisting pattern around baseline
  • Treatment: IV Magnesium sulfate 2g (8 mmol) over 10 minutes (= 4 mL of 50% magnesium = 8 mL of 25%)
  • Unsynchronised shock if haemodynamically unstable/pulseless
  • Identify and correct precipitating cause: QT-prolonging drugs (antipsychotics/macrolides/methadone), hypokalaemia, hypomagnesaemia
  • Avoid amiodarone — prolongs QT further
  • Consider isoproterenol infusion or temporary pacing to increase heart rate (>90/min) and shorten QT
Quick Arrhythmia Reference
ArrhythmiaFirst DrugEnergy (if shock)
VF / Pulseless VTAdrenaline 1mg (after 3rd shock)200J biphasic (unsynchronised)
Haemodynamically unstable any tachycardiaSynchronised DC cardioversion120–150J start
Stable VT (broad)Amiodarone 300mg IV over 20–60 min
SVT (narrow)Modified Valsalva → Adenosine 6mg
Bradycardia (symptomatic)Atropine 500mcg IV
Torsades de PointesMagnesium 2g IV over 10 minUnsynchronised if pulseless
WPW + AFDC Cardioversion or Flecainide120–150J synchronised
Targeted Temperature Management (TTM)
Target: 32–36°C for 24 hours Indicated in comatose survivors of OHCA (GCS <8 after ROSC). HYPERION trial (2019): TTM at 33°C beneficial in non-shockable rhythms. TTM2 trial (2021): no significant difference between 33°C vs normothermia — but FEVER PREVENTION is essential regardless.
  • Active cooling methods: IV cold saline (4°C, 30 mL/kg) for rapid induction, external cooling blankets/vest devices (Arctic Sun, EMCOOLS), nasal high-flow cold oxygen
  • Temperature monitoring: continuous oesophageal thermometer (most accurate) or bladder catheter thermometer; not axillary or oral
  • Shivering management: sedation (propofol/midazolam/fentanyl) + neuromuscular blockade (rocuronium) if needed — shivering raises core temperature and increases O₂ consumption
  • Rewarming: gradual at 0.25–0.5°C/hour after 24h — avoid rebound hyperthermia
  • Strictly avoid fever (>37.7°C) for 72h post-arrest — worsens neurological outcome (strong evidence)
Ventilation Targets Post-ROSC
ParameterTargetRationale
SpO₂94–98%Avoid hyperoxia — free radical injury to reperfused brain
PaO₂11–16 kPa (80–120 mmHg)Titrate FiO₂ to achieve SpO₂ target
PaCO₂4.5–6.0 kPa (34–45 mmHg)Normocapnia — hypocapnia causes cerebral vasoconstriction
Tidal volume6–8 mL/kg IBWLung-protective ventilation
PEEP5–8 cmH₂OPrevent atelectasis, optimise oxygenation
Haemodynamic Management
  • MAP target: ≥65 mmHg (some centres aim MAP 80–100 mmHg in cardiac arrest survivors — improves cerebral perfusion pressure)
  • First-line vasopressor: noradrenaline (norepinephrine) infusion — titrate to MAP target
  • Dobutamine/inotropes if low cardiac output (PCWP elevated, poor CO on echo)
  • IABP/Impella/VA-ECMO: consider in refractory cardiogenic shock post-arrest
  • 12-lead ECG immediately post-ROSC — identify STEMI or new LBBB → cath lab activation
Coronary Angiography Post-Arrest
Evidence: COACT (2019) & TOMAHAWK (2021) Trials Both trials showed NO benefit of immediate vs. delayed coronary angiography in OHCA survivors without STEMI. Current recommendation: immediate cath lab for STEMI or high suspicion of cardiac cause. For non-STEMI OHCA — delayed angiography after ICU stabilisation acceptable.
  • Activate cath lab pathway for post-arrest STEMI or new LBBB on ECG
  • Continue TTM during PCI — dual therapy possible
  • Ensure anticoagulation (heparin/bivalirudin) and antiplatelet (aspirin + P2Y12 inhibitor)
Neuroprognostication
Multimodal Assessment at ≥72h Post-ROSC Single tests are unreliable. Combine: clinical exam + neurophysiology + imaging + biomarkers. TTM confounds early assessment — wait minimum 72h after ROSC and 24h after normothermia.
  • Clinical exam: pupillary light reflex (absent bilaterally at 72h = poor sign), corneal reflex, myoclonus (generalised myoclonus within 48h = poor), GCS trends, motor response
  • EEG: background activity (burst suppression/flat = poor), seizure activity (up to 36% post-arrest)
  • SSEP (Somatosensory Evoked Potentials): bilateral absent N20 waves = strong predictor of poor outcome
  • Neuroimaging: CT (cerebral oedema — reduced grey/white differentiation), MRI at 2–5 days (DWI for cortical injury extent)
  • Biomarkers: NSE (Neuron-Specific Enolase) >60 mcg/L at 48–72h = poor prognosis; S100B protein elevated = astrocyte injury
  • Avoid premature withdrawal of life-sustaining treatment — minimum 72h post-ROSC assessment
ICU Nursing Care Post-Arrest
  • Neurological observations: GCS/FOUR score hourly, pupillary light reflex and size, motor response changes
  • Continuous EEG monitoring for non-convulsive status epilepticus (NCSE)
  • Glycaemic control: target 6–10 mmol/L (avoid hypoglycaemia — worsens cerebral outcome)
  • Skin care: pressure area care, reposition 2-hourly, cooling device skin checks
  • Fluid balance: strict hourly urine output, target >0.5 mL/kg/h
  • Oral/ETT care: subglottic suctioning ETT, mouth care every 4h, HOB 30–45°
  • DVT prophylaxis: compression stockings, consider LMWH when haemostasis confirmed
Resuscitation Team Roles
Team Leader
Stand back, see whole picture. Direct team. Time-keeping. Make decisions. Summarise situation. Brief team on plan. NOT the compressor.
Chest Compressor
High-quality CPR. Rotate every 2 min without pause. Handover technique: next compressor positions hands then takes over on "switch."
Airway Operator
BVM ventilation / SGA / ETI. Confirm tube position. Coordinate ventilation rate with compressions after advanced airway.
Drugs Nurse
IV/IO access. Draw up and administer drugs. Document dose and time. Announce administration to team.
Recorder
Real-time documentation: time of arrest, CPR start, each shock (energy + time), each drug (dose + time), rhythm changes, ROSC time, outcome.
Family Liaison
Separate nurse allocated. Keeps family informed, supports them, facilitates family presence (evidence-based benefit). Cultural sensitivity in GCC.
Closed-Loop Communication
3-Step Communication Standard 1. Leader directs by NAME + TASK + TIME: "Sara, give 1mg adrenaline IV now."
2. Receiver acknowledges: "Sara, giving 1mg adrenaline IV now." (read-back)
3. Receiver confirms completion: "1mg adrenaline given at 14:32."
Leader acknowledges: "Thank you, Sara."
  • Use names — reduces confusion in loud, stressful environments
  • No ambiguous orders — specify route (IV/IO), concentration, rate
  • Leader summarises status every 2 min cycle to keep all team informed
  • Challenge dangerous orders respectfully ("I need to confirm — you want 10mg, not 1mg?")
Resuscitation Documentation Checklist
  • Time of witnessed/suspected cardiac arrest
  • Time CPR started and by whom
  • Initial rhythm identified
  • Time and energy of each defibrillation attempt
  • Each drug: name, dose, route, time
  • IV/IO access established — site and time
  • Airway interventions and tube confirmation method
  • ROSC time (if achieved)
  • Post-ROSC management initiated
  • Time resuscitation discontinued (if applicable) + decision-maker
  • Family notification time and who was informed
Crew Resource Management (CRM) in Resus
  • Situational awareness: each team member maintains awareness of overall situation — "what is happening now, what is about to happen"
  • Shared mental model: all team members understand current plan and next steps
  • Speak up culture: psychological safety — junior can challenge senior if safety concern
  • Manage workload: leader redistributes tasks if team member overloaded
  • Avoid fixation errors: leader periodically steps back to reassess — "are we missing something?"
  • Re-evaluation: after each 2-min cycle — is the diagnosis correct? Any reversible causes missed?
Debriefing After Resuscitation
Hot Debrief (Immediate — within 5 minutes) Brief, structured. "What went well? What could be improved? Is anyone needing support?" Led by team leader. Maximum 5 minutes. Focus on process, not blame.
Cold Debrief (24–48h later) Formal multidisciplinary debrief. Review documentation. Identify learning points. Address emotional impact on staff. Consider resuscitation audit and feedback to team.
  • Normalise emotional responses — cardiac arrest affects all team members
  • Identify staff needing additional support (occupational health/chaplaincy/psychology)
  • Promote psychological safety — debrief is learning, not blame allocation
Dignity & Cultural Considerations (GCC)
  • Family presence during resuscitation: evidence supports psychological benefit for family — assign dedicated liaison nurse, offer choice, explain what is happening
  • GCC cultural expectation: immediate notification of direct family (parents/spouse) is both a cultural and often legal expectation — do not delay family notification
  • Patient dignity: screen patient from corridor, drape appropriately, limit unnecessary exposure, remove non-essential bystanders
  • Religious considerations: facilitate religious rites if resuscitation discontinued — chaplain/imam contact promptly
  • Gender considerations: same-gender resuscitation team where possible in appropriate cultural context
  • Documentation in Arabic: some GCC facilities require bilingual documentation — follow local policy
GCC Resuscitation Landscape
  • Saudi Heart Association (SHA): issues ALS guidelines closely aligned with ERC 2021. ACLS provider courses widely available in Saudi Arabia.
  • Emirates Cardiac Society: ERC-aligned guidelines; Dubai Health Authority (DHA) and DoH Abu Dhabi mandate ALS certification for critical care nurses.
  • SCFHS (Saudi Commission for Health Specialties): ALS/ACLS certification required for ICU/ED/Anaesthesia nursing licensing and specialty credentials.
  • Bystander CPR in GCC: historically low rates improving through public awareness campaigns, Hands-Only CPR in Arabic, and mandatory CPR training in schools in UAE/KSA.
  • AED placement: now mandatory in malls, mosques, airports, hotels across GCC — MOHAP UAE, MoH KSA regulations mandate AED availability and trained responders.
  • Public CPR campaigns: Qatar Cardiac Society, KSA Heart Association "Hands-Only CPR" drives increasing community responder rates.
ALS Drug Dose Calculator
Drug / InterventionDoseNotes
DHA / DOH / SCFHS MCQ Practice (10 Questions)